Telocytes pp 207-228 | Cite as

Primary Extragastrointestinal Stromal Tumours in the Hepatobiliary Tree and Telocytes

  • Somanath Padhi
  • Hemanta Kumar Nayak
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 913)


The first decade of the twenty-first century witnessed the presence and light microscopic, immunophenotypic, and ultrastructural characterization of interstitial Cajal-like cells (coined as ‘telocytes’) in virtually every extragastrointestinal site of the human body by Laurentiu M. Popescu and his co-workers. Not surprisingly, stromal tumours, immunophenotypically similar to that of telocytes [CD117 (c-KIT) +/CD34 +], have also been sporadically reported outside the tubular gut (so-called extragastrointestinal stromal tumours, EGISTs), including the gall bladder, liver, and pancreas. A meticulous literature search from January 2000 to November 2015 have found 9 such case reports of EGISTs in the gall bladder, 16 in the liver, and 31 occurring in the pancreas. The site wise mean age at presentation for these tumours were reported to be 62.2 ± 16.6, 50.9 ± 20.1, and 55.3 ± 14.3 years, respectively. Six of nine EGISTs in the gall bladder were associated with gallstones. On pathological evaluation, these tumours exhibited prominent spindled cell morphology and consistent expression of CD117/c-KIT and CD34 on immunohistochemistry and variable expression of vimentin and α-smooth muscle actin. The biological behaviour of hepatic and pancreatic lesions was favourable compared to that in the gall bladder, following definitive surgery with or without imatinib therapy. While the exact pathophysiologic role played by telocytes in various organs is yet to be fully elucidated, there seems to be a direct link between these enigmatic stromal cells and pathogenesis of gallstones and origin of EGISTs, and a hope for targeted therapies. Furthermore, the possible role of telocytes in hepatic regeneration and liver fibrosis opens a new dimension for futuristic research.


EGIST Gall bladder Gallstones Liver Telocytes 



The authors would like to thank Professor Laurentiu M. Popescu for his inspiration and allowing us to use some of the figures related to telocytes from the Journal of Cellular and Molecular Medicine. The authors would also like to thank Professor Renu G’Boy Varghese, Department of Pathology at Pondicherry Institute of Medical Sciences, Pondicherry, India, for reviewing the cases and the tables in the manuscript.

Financial Support/Grant

None declared.

Conflict of Interest

The authors declare that there is no conflict of interest.


  1. 1.
    Tan CB, Zhi W, Shahzad G, Mustacchia P. Gastrointestinal stromal tumors: a review of case reports, diagnosis, treatment, and future directions. ISRN Gastroenterology. 2012. Article ID 595968.Google Scholar
  2. 2.
    Laurini JA, Carter JE. Gastrointestinal stromal tumors: a review of the literature. Arch Pathol Lab Med. 2010;134:134–41.PubMedGoogle Scholar
  3. 3.
    Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, et al. Diagnostic relevance of overexpression of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six center study of 28 cases. Anticancer Res. 2012;32:923–37.PubMedGoogle Scholar
  4. 4.
    Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, et al. Diagnostic significance of DOG-1 and PKC-θ expression and c-KIT/PDGFRA mutations in gastrointestinal stromal tumours. Scand J Gastroenterol. 2013;48:1055–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Kara T, Serinsoz E, Arpaci RB, Gubur O, Orekici G, Ata A, et al. Contribution of DOG-1 to the diagnosis of gastrointestinal stromal tumors. Pathol Res Pract. 2013;209:413–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Sun XW, Feng ZJ, Huang P, Hao W, Sui XL. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology. Asian Pac J Cancer Prev. 2012;13:1389–93.CrossRefPubMedGoogle Scholar
  7. 7.
    Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.PubMedGoogle Scholar
  8. 8.
    Weiss SW, Goldblum JR. Extra gastrointestinal stromal tumors. In: Enzinger and Weiss’s soft tissue tumors. 5th ed. Mosby Elesevier; 2008; p. 565–79. ISBN 978-0-323-04628-2.Google Scholar
  9. 9.
    Rieth JD, Goldblum JR, Lyles RH, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13:577–85.CrossRefGoogle Scholar
  10. 10.
    Popescu LM, Faussone-Pellegrini MS. TELOCYTES – a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010;14:729–40.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Nicolescu MI, Popescu LM. Telocytes in the interstitium of human exocrine pancreas: ultrastructural evidence. Pancreas. 2012;41:949–56.CrossRefPubMedGoogle Scholar
  12. 12.
    Popescu LM, Hinescu ME, Ionescu N, Ciontea SM, Cretoiu D, Ardelean C. Interstitial cells of Cajal in pancreas. J Cell Mol Med. 2005;9:169–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Cretoiu SM, Cretoiu D, Marin A, Radu BM, Popescu LM. Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction. 2013. doi: 10.1530/REP-12-0369.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Hinescu ME, Ardeleanu C, Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells in human gall bladder. J Mol Hist. 2007;38:275–84.CrossRefGoogle Scholar
  15. 15.
    Ahmadi O, Nicholson Mde L, Gould ML, Mitchell A, Stringer MD. Interstitial cells of Cajal are present in human extrahepatic bile ducts. J Gastroenterol Hepatol. 2010;25:277–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Pasternak A, Gajda M, Gil K, Matyja A, Tomaszewski KA, Walocha JA, Kulig J, Thor P. Evidence of interstitial Cajal-like cells in human gallbladder. Folia Histochem Cytobiol. 2012;50:581–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Rusu MC, Pop F, Hostiuc S, Curca GC, Streinu-Cercel. Extrahepatic and intrahepatic human portal interstitial Cajal cells. Anat Rec. 2011;294:1382–92.CrossRefGoogle Scholar
  18. 18.
    Joseph P, Goyal R, Bansal P, Parmar R, Dutt S. Pancreatic extra-gastrointestinal stromal tumour with documentation of C-Kit mutation: a case report. J Clin Diagn Res. 2015;9:ED17–8.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Akbulut S, Yavuz R, Otan E, Hatipoglu S. Pancreatic extragastrointestinal stromal tumor: a case report and comprehensive literature review. World J Gastrointest Surg. 2014;6:175–82.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Padhi S, Sarangi R, Mallick S. Pancreatic extragastrointestinal stromal tumors, interstitial Cajal like cells, and telocytes. JOP. 2013;14:1–14.PubMedGoogle Scholar
  21. 21.
    Ortiz-Hidalgo C, De Leon Bojorge B, Albores-Saavedra J. Stromal tumor of the gallbladder with phenotype of interstitial cells of Cajal: a previously unrecognized neoplasm. Am J Surg Pathol. 2000;24:1420–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Mendoza-Marin M, Hoang MP, Albores-Saavedra J. Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med. 2002;126:481–3.PubMedGoogle Scholar
  23. 23.
    Park JK, Choi SH, Lee S, Min KO, Yun SS, Jeon HM. Malignant gastrointestinal stromal tumor of the gallbladder. JKMS. 2004;19:763–7.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Peerlinck ID, Irvin TT, Sarsfield PT, Harington JM. GIST (gastro-intestinal stromal tumour) of the gallbladder: a case report. Acta Chir Belg. 2004;104:107–9.PubMedGoogle Scholar
  25. 25.
    Furihata M, Fujimori T, Imura J, Ono Y, Furihata T, Shimoda M, Kato M, Kita J, Ohkura Y, Kubota K. Malignant stromal tumor, so called “gastrointestinal stromal tumor”, with rhabdomyomatous differentiation occurring in the gallbladder. Pathol Res Pract. 2005;201:609–13.CrossRefPubMedGoogle Scholar
  26. 26.
    Al-Daraji WI, Prescott RJ, Al-Mahmoud RM, Husain EA, Haider SA. Cytological findings in a primary GIST of the gallbladder. Cytopathology. 2009;20:332–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Petrou A, Alexandrou P, Papalambros A, Saetta A, Fragkou P, Kontos M, et al. A malignant gastrointestinal stromal tumor of the gallbladder immunoreactive for PDGFRA and negative for CD 117 antigen (c-KIT). HPB Surg. 2011;2011:327192.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Bolanaki H, Delladetsima I, Argyropoulou P, Kapranou A, Kakolyris S, Simopoulos C, et al. Primary malignant gastrointestinal stromal tumor (GIST) of the gallbladder: report of a case. J Gastrointest Cancer. 2012;43:S151–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Kostov DV, Kobakov GL. Gastrointestinal stromal tumour of the gallbladder. HPB (Oxford). 2012;14:150.CrossRefGoogle Scholar
  30. 30.
    Hu X, Forster J, Damjanov I. Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med. 2003;127:1606–8.PubMedGoogle Scholar
  31. 31.
    Pai JJ, Khan N, Balart LA. Primary hepatic gastrointestinal stromal tumor. Am J Gastroenterol. 2003;98:S163.CrossRefGoogle Scholar
  32. 32.
    De Chiara A, De Rosa V, Lastoria S, Franco R, Botti G, Iaffaioli VR, et al. Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate). Front Biosci. 2006;11:498–501.CrossRefPubMedGoogle Scholar
  33. 33.
    Ochiai T, Sonoyama T, Kikuchi S, Ikoma H, Kubota T, Nakanishi M, et al. Primary large gastrointestinal stromal tumor of the liver: report of a case. Surg Today. 2009;39:633–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Terada T. Gastrointestinal stromal tumor of the digestive organs: a histopathologic study of 31 cases in a single Japanese institute. Int J Clin Exp Pathol. 2010;3:162–8.Google Scholar
  35. 35.
    Luo XL, Liu D, Yang JJ, Zheng MW, Zhang J, Zhou XD. Primary gastrointestinal stromal tumor of the liver: a case report. World J Gastroenterol. 2009;15:3704–7.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Yamamoto H, Miyamoto Y, Nishihara Y, Kojima A, Imamura M, Kishikawa K, et al. Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation. Hum Pathol. 2010;41:605–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Alecu L, Tulin A, Ursut B, Ursut B, Oproiu A, Obrocea F, et al. Gastrointestinal stromal tumor with primary hepatic unique location – clinical case. Chirurgia (Bucur). 2011;106:677–81.Google Scholar
  38. 38.
    Abedalthagafi M. Gastrointestinal stromal tumor originating from hepatic falciform ligament. BMJ Case Rep. 2012. doi: 10.1136/bcr-03-2012-6136.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Li ZY, Liang QL, Chen GQ, Zhou Y, Liu QL. Extra-gastrointestinal stromal tumor of the liver diagnosed by ultrasound-guided fine needle aspiration cytology: a case report and review of the literature. Arch Med Sci. 2012;8:392–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Hayashi H, Iseki M, Kawabata M, Nonoshita M, Yamamoto H, Shimokwa I. Primary hepatic gastrointestinal stromal tumor showing remarkable myxoid change and hemangiopericytoma-like pattern. Acta Med Nagasaki. 2013;58:19–24.Google Scholar
  41. 41.
    Zhou B, Zhang M, Yan S, Zheng S. Primary gastrointestinal stromal tumor of the liver: report of a case. Surg Today. 2014;44:1142–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Louis AR, Singh S, Gupta SK, Sharma A. Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver. J Gastrointest Cancer. 2014;45:392–4.CrossRefPubMedGoogle Scholar
  43. 43.
    Kim HO, Kim JE, Bae KS, Choi BH, Jeong CY, Lee JS. Imaging findings of primary malignant gastrointestinal stromal tumor of the liver. Jpn J Radiol. 2014;32:365–70.CrossRefPubMedGoogle Scholar
  44. 44.
    Mao L, Chen J, Liu Z, Liu CJ, Tang M, Qiu YD. Extracorporeal hepatic resection and autotransplantation for primary gastrointestinal stromal tumor of the liver. Transplant Proc. 2015;47:174–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Lin XK, Zhang Q, Yang WL, Shou CH, Liu XS, Sun JY, et al. Primary gastrointestinal stromal tumor of the liver treated with sequential therapy. World J Gastroenterol. 2015;21:2573–6.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Long KB, Butrynski JE, Blank SD, Ibrahim KS, Dressel DM, Heinrich MC, et al. Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation. Am J Surg Pathol. 2010;34:907–12.CrossRefPubMedGoogle Scholar
  47. 47.
    Papaspyros S, Papagiannopoulos K. Gastrointestinal stromal tumor masquerading as a lung neoplasm: a case presentation and literature review. J Cardiothorac Surg. 2008;3:31–4.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Peitsidis P, Zarganis P, Trichia H, Vorgias G, Smith JR, Akrivos T. Extragastrointestinal stromal tumor mimicking a uterine tumor. A rare clinical entity. Int J Gynecol Cancer. 2008;18:1115–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999;154:53–60.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Wardelmann E, Losen I, Hans V, Neidt I, Speidel N, Bierhoff E, et al. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. Int J Cancer. 2003;106:887–95.CrossRefPubMedGoogle Scholar
  51. 51.
    Gramza AW, Corles CL, Heinrich MC. Resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumors. Clin Cancer Res. 2009;15:7510–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Debiec-Rychter M, Lasota J, Sarlomo-Rikala M, Kordek R, Miettinen M. Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genet Cytogenet. 2001;128:24–30.CrossRefPubMedGoogle Scholar
  53. 53.
    Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.CrossRefPubMedGoogle Scholar
  54. 54.
    Xiao J, Wang F, Liu Z, Yang C. Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med. 2013;17:1537–42.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Huang Y, Mei F, Yu B, Zhang HJ, Han J, Jiang ZY, et al. Distribution of the interstitial Cajal-like cells in the gallbladder and extrahepatic biliary duct of the guinea-pig. Acta Histochem. 2009;111:157–65.CrossRefPubMedGoogle Scholar
  56. 56.
    Pasternak A, Gil K, Matyja A, Gajda M, Sztefko K, Walocha JA, et al. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol Motil. 2013;25:e17–24.CrossRefPubMedGoogle Scholar
  57. 57.
    Matyja A, Gil K, Pasternak A, Sztefko K, Gajda M, Tomaszewski KA, et al. Telocytes: new insight into the pathogenesis of gallstone disease. J Cell Mol Med. 2013. doi: 10.1111/jcmm.12057.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Fu S, Wang F, Cao Y, Huang Q, Xiao J, Yang C, et al. Telocytes in human liver fibrosis. J Cell Mol Med. 2015;19:676–83.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Franks I. Gallbladder: loss of interstitial Cajal-like cells in the gallbladder might contribute to gallstone formation. Nat Rev Gastroenterol Hepatol. 2012;9:689.CrossRefPubMedGoogle Scholar
  60. 60.
    Wang F, Song Y, Bei Y, Zhao Y, Xiao J, Yang C. Telocytes in liver regeneration: possible roles. J Cell Ther. 2016;11:415–9.Google Scholar
  61. 61.
    Liu J, Cao Y, Song Y, Huang Q, Wang F, Yang W, Yang C. Telocytes in the liver. Curr Stem Cell Ther. 2016;11:415–9.Google Scholar

Copyright information

© Springer Science+Business Media Singapore 2016

Authors and Affiliations

  1. 1.Department of Pathology and Lab MedicineAll India Institute of Medical SciencesBhubaneswarIndia
  2. 2.Department of GastroenterologySanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations